Dismantling Silos: Why Those Who Fight Cancer and Environmental Dangers Must Join Forces goodmenproject.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from goodmenproject.com Daily Mail and Mail on Sunday newspapers.
– Total revenues of $881 million in the first quarter
– Jakafi® net product revenues of $572 million in Q1 24, total paid patients increased +5% Y/Y; reiterating full year 2024 guidance of.
HC Wainwright reiterated their buy rating on shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) in a research report released on Friday, Benzinga reports. HC Wainwright currently has a $41.00 price objective on the stock. Other analysts have also issued reports about the stock. StockNews.com upgraded shares of Syndax Pharmaceuticals to a sell rating in […]
Syndax Pharmaceuticals (SNDX) Buy Rating Reaffirmed at HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Biofrontera (NASDAQ:BFRI – Get Free Report) and Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership. Profitability This table compares Biofrontera and Syndax Pharmaceuticals’ […]